基于miR-204表达预测IgA肾病进展风险的初步研究
该初步研究探讨尿外泌体及肾组织miR-204表达与IgA肾病进展风险的关系。结果显示进展高风险患者miR-204表达显著降低,曲线下面积0.82,将其加入国际IgA肾病风险预测工具可提升预测效能。
要点
- IgA肾病患者尿外泌体miR-204表达较健康人显著降低。
- 进展高风险患者肾组织miR-204表达显著低于低风险者。
- miR-204加入国际IgA肾病风险预测工具可改善预测能力。
核心结论
- miR-204表达降低与IgA肾病进展高风险相关,可能作为风险预测的辅助生物标志物。
研究设计与样本
- 初步研究,比较IgA肾病与非IgA肾病慢性肾脏病对照及健康受试者的miR-204表达,并在独立队列中验证。
主要发现
- 尿外泌体miR-204在IgA肾病中较健康人显著降低,但与未报告的非IgA肾病慢性肾脏病对照无差异。
- 肾活检组织中miR-204在IgA肾病中较薄基底膜肾病显著降低,但与膜性肾病无差异。
- IgA肾病进展高风险患者miR-204表达显著低于低风险患者。
- IgA肾病非进展者miR-204优先表达于间质而非肾小球,进展者该分布丢失。
- 两IgA肾病队列间ROC曲线下面积为0.82,且miR-204表达与已知临床病理预后风险因素相关。
关键数值与推荐
- ROC曲线下面积为0.82(两IgA肾病队列间)。
- 将miR-204纳入国际IgA肾病风险预测工具可改善算法预测进展风险的诊断效能。
临床怎么用
- miR-204表达检测可能辅助识别IgA肾病进展高风险患者,但需进一步验证。
局限性
- 初步研究,需大规模研究验证miR-204在IgA肾病及慢性肾脏病风险预测中的附加价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Immunoglobulin (Ig)A nephropathy (IgAN) is the most frequently diagnosed primary glomerulonephritis worldwide. Despite the common diagnostic feature of mesangial IgA-containing immune complex deposition, the clinical course of the disease is extremely variable, with 30% of patients developing end-stage kidney disease within 20 years of diagnosis. Therefore, identifying which patients are likely to progress is paramount. RESULTS: In this pilot study, we found that urinary exosomal miR-204 expression was significantly reduced in IgAN compared with healthy subjects. However, there was no difference in miR-204 expression between IgAN and non-IgAN chronic kidney disease controls. Analysis of miR-204 expression in kidney biopsy cores by next-generation sequencing followed by quantitative polymerase chain reaction validation in independent cohorts demonstrated that expression of miR-204 was significantly lower in IgAN compared with thin-membrane nephropathy but not compared with membranous nephropathy. Patients with IgAN at high risk of future progression had significantly lower expression of miR-204 than those at low risk of progression. Cortical localization indicated that miR-204 was preferentially expressed in the interstitium compared with glomeruli in IgAN nonprogressors and that this distribution was lost in IgAN progressors. Receiver operating characteristic curve analysis between the 2 IgAN cohorts revealed an area under the curve of 0.82. In addition, miR-204 expression correlated with known clinicopathological prognostic risk factors. Importantly, incorporating miR-204 into the International IgAN risk prediction tool improved the diagnostic power of the algorithm to predict risk of progression. CONCLUSION: Additional large-scale studies are now needed to validate the additive value of miR-204 in improving risk prediction in IgAN and more broadly in chronic kidney disease.
引用
- Pawluczyk I, Nicholson M, Barbour S, et al. A Pilot Study to Predict Risk of IgA Nephropathy Progression Based on miR-204 Expression. Kidney Int Rep. 2021. PMID: 34386667. doi:10.1016/j.ekir.2021.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。